Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from Cancer Research UK, between 2022 and 2024, around 247 people per 100,000 ...

Pancreatic cancer is one of the most dangerous and difficult cancers to treat. Doctors often struggle to detect it early because the disease usually causes few symptoms in the beginning. By the time ...

Pancreatic cancer is widely known as one of the most dangerous and difficult cancers to treat. Among the different types of pancreatic cancer, the most common and aggressive form is called pancreatic ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

Jean Trebek, Lisa Swayze, Joan Vassos, Stephen Nichols, Jeff Mauro, Jonathan Frakes, Kitty Swink, Rosa Blasi and Many More Raise [...] READ MORE ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

Two sisters have issued a warning after losing both of their healthy parents to a 'silent killer' form of cancer ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic ...

Piedmont Oncology announced a significant philanthropic gift to support its Early Detection Pancreatic Cancer Clinic (EDC) and to establish an endowed medical director position for the clinic. This ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...